Jw Life Science Corp Cash Flow Conversion Efficiency

Latest as of June 2026: 0.077x

Jw Life Science Corp cash flow conversion efficiency. Based on the latest financial reports, Jw Life Science Corp (234080) has a cash flow conversion efficiency ratio of 0.077x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩17.43 Billion ≈ $11.82 Million USD) by net assets (₩226.76 Billion ≈ $153.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 234080 stock market capitalisation for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of Jw Life Science Corp (2015–2025)

Cash flow conversion efficiency of Jw Life Science Corp from 2015 to 2025. This chart illustrates how Jw Life Science Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Jw Life Science Corp stock price today for real-time trading data and today's change.

Jw Life Science Corp Cash Flow Conversion Ratio Explained

Jw Life Science Corp cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Jw Life Science Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jw Life Science Corp ranked by their cash flow conversion efficiency. Review 234080 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
Optical Cable Corporation NASDAQ:OCC	0.062x
Luxchem Corporation Bhd KLSE:5143	-0.001x
ARRAIL GROUP LTD. F:I1D	N/A
D&D Platform Reit Co Ltd KO:377190	N/A
Schroders PLC LSE:SDR	0.043x
Mosa Industrial Corp TW:4564	0.027x
Amotech Co. Ltd KQ:052710	0.021x
Grupo Sports World S.A.B. de C.V MX:SPORTS	0.421x

Annual Cash Flow Conversion Efficiency for Jw Life Science Corp (2015–2025)

The table below shows the annual cash flow conversion efficiency of Jw Life Science Corp from 2015 to 2025. Also see Jw Life Science Corp balance sheet assets for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩220.58 Billion ≈ $149.48 Million	₩40.54 Billion ≈ $27.47 Million	0.184x	-27.33%
2024-12-31	₩200.44 Billion ≈ $135.84 Million	₩50.69 Billion ≈ $34.35 Million	0.253x	+7.28%
2023-12-31	₩159.39 Billion ≈ $108.02 Million	₩37.57 Billion ≈ $25.46 Million	0.236x	+134.14%
2022-12-31	₩140.33 Billion ≈ $95.10 Million	₩14.13 Billion ≈ $9.57 Million	0.101x	-56.11%
2021-12-31	₩131.49 Billion ≈ $89.11 Million	₩30.17 Billion ≈ $20.44 Million	0.229x	-35.20%
2020-12-31	₩132.06 Billion ≈ $89.50 Million	₩46.75 Billion ≈ $31.68 Million	0.354x	+78.82%
2019-12-31	₩122.62 Billion ≈ $83.09 Million	₩24.28 Billion ≈ $16.45 Million	0.198x	-40.13%
2018-12-31	₩109.26 Billion ≈ $74.04 Million	₩36.13 Billion ≈ $24.48 Million	0.331x	+53.12%
2017-12-31	₩102.10 Billion ≈ $69.19 Million	₩22.05 Billion ≈ $14.94 Million	0.216x	+21.27%
2016-12-31	₩90.30 Billion ≈ $61.20 Million	₩16.08 Billion ≈ $10.90 Million	0.178x	-43.04%
2015-12-31	₩82.83 Billion ≈ $56.13 Million	₩25.90 Billion ≈ $17.55 Million	0.313x	--

About Jw Life Science Corp

KO:234080 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$111.13 Million

₩163.98 Billion KRW

Market Cap Rank

#18655 Global

#856 in Korea

Share Price

₩10590.00

Change (1 day)

+0.76%

52-Week Range

₩10420.00 - ₩15500.00

All Time High

₩26817.34